about
Rationale for and protocol of a multi-national population-based bacteremia surveillance collaborativeImmunization in Canada: a 6-year updateCost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada.Pneumococcal conjugate vaccination in Canadian infants and children younger than five years of age: Recommendations and expected benefits.Mortality reductions for older adults differ by race/ethnicity and gender since the introduction of adult and pediatric pneumococcal vaccinesPneumococcal vaccination: what have we learnt so far and what can we expect in the future?Presentation and management of pediatric orbital cellulitisStreptococcus pneumoniae meningitis in Alberta pre- and postintroduction of the 7-valent pneumococcal conjugate vaccine.Decline in pneumococcal meningitis after the introduction of the heptavalent-pneumococcal conjugate vaccine in northern FranceThe burden of pneumococcal disease in the Canadian population before routine use of the seven-valent pneumococcal conjugate vaccine.A cost-effectiveness analysis of a 10-valent pneumococcal conjugate vaccine in children in six Latin American countries.Global prevailing and emerging pediatric pneumococcal serotypes.Impact of 10-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children up to two years of age in Brazil.Conjugate vaccines and polysaccharide response.Incidence of invasive pneumococcal disease in the Czech Republic and serotype coverage by vaccines, 1997-2006.
P2860
Q33485564-45DDBBED-297A-4272-BABA-954084E1A39DQ33874745-81923AA2-C0A0-47AB-B9B9-EFA28FF8AB2CQ34244232-CD5323BC-3A26-4796-848A-F374BCDCD5FAQ34590621-1914DA68-A58A-4953-8A52-E5D6816095CDQ34663884-386B3729-C1AB-4406-A4E2-4547F9E4F45AQ34798448-29CACC47-7C5F-4E80-8E7C-202D50DA9161Q35433979-318ADC14-77FE-4CA9-8E8D-A9245A14201DQ35569198-D5CCA610-67E3-41C0-BE6E-1AEC44D64375Q36155052-4ABDEEB0-33BC-4B89-858D-0480CCCC8A27Q36871048-0299273D-FDE6-454D-81D5-18EB6E224587Q37153913-DC3975DA-785A-4CE5-9110-11A5C5832412Q37821484-D9912A37-E200-4800-BCE7-DED69075D946Q41247311-19FC3DFB-B03C-4F21-B9BC-54296CABC3EAQ43244617-8173C51A-2673-4543-9C7B-7C6B7CA1CA81Q51122671-CA714668-F6EC-44D3-845F-04A9514CFFD2
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Progress in the prevention of pneumococcal infection.
@ast
Progress in the prevention of pneumococcal infection.
@en
Progress in the prevention of pneumococcal infection.
@nl
type
label
Progress in the prevention of pneumococcal infection.
@ast
Progress in the prevention of pneumococcal infection.
@en
Progress in the prevention of pneumococcal infection.
@nl
prefLabel
Progress in the prevention of pneumococcal infection.
@ast
Progress in the prevention of pneumococcal infection.
@en
Progress in the prevention of pneumococcal infection.
@nl
P2093
P356
P1476
Progress in the prevention of pneumococcal infection
@en
P2093
Deirdre L Church
Gregory J Tyrrell
Judy MacDonald
P304
P356
10.1503/CMAJ.051150
P407
P577
2005-11-01T00:00:00Z